Health Care & Life Sciences » Pharmaceuticals | AFT Pharmaceuticals Ltd.

AFT Pharmaceuticals Ltd. | Cash Flow

Fiscal year is April-March. All values NZD Thousands.
2015
2016
2017
2018
2019
Net Income before Extraordinaries
12,873.00
13,267.00
18,388.00
12,724.00
2,427
Depreciation, Depletion & Amortization
228.00
268.00
326.00
340.00
319
Other Funds
95.00
1,773.00
1,365.00
1,746.00
4,294
Funds from Operations
12,550.00
14,772.00
16,697.00
10,638.00
2,186
Changes in Working Capital
555.00
343.00
2,365.00
266.00
4,679
Net Operating Cash Flow
13,105.00
14,429.00
19,062.00
10,904.00
2,493
Capital Expenditures
488.00
704.00
742.00
2,853.00
Sale of Fixed Assets & Businesses
5.00
10.00
-
-
Purchase/Sale of Investments
-
-
856.00
3,002.00
Net Investing Cash Flow
483.00
694.00
1,598.00
5,855.00
Cash Dividends Paid - Total
763.00
1,652.00
-
412.00
Issuance/Reduction of Debt, Net
5,039.00
-
-
7,135.00
Net Financing Cash Flow
17,135.00
36,705.00
9,042.00
7,600.00
Net Change in Cash
3,452.00
23,355.00
12,075.00
9,135.00
Free Cash Flow
13,244.00
14,577.00
19,184.00
10,974.00
Change in Capital Stock
12,859.00
38,357.00
9,042.00
877.00
Exchange Rate Effect
95.00
1,773.00
457.00
24.00

About AFT Pharmaceuticals

View Profile
Address
Nielsen House
Auckland AU 0622
New Zealand
Employees -
Website http://www.aftpharm.com
Updated 07/08/2019
AFT Pharmaceuticals Ltd. engages in the development, licensing, and distribution of medical and pharmaceutical products. Its feature brands include Crystaderm, Maxigesic, Coco-Scalp, Maxiclear, Eyecare Hub, and Allergy Hub. It operates through the following geographical segments: Australia, New Zealand, Asia, and Rest of the World.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.